Research Nester published a report titled “Oxycodone Market: Global Demand Analysis & Opportunity Outlook 2030” which delivers detailed overview of the global oxycodone market in terms of market segmentation by route of administration, application, end-user, and by region.
Further,
for the in-depth analysis, the report encompasses the industry growth
indicators, restraints, supply and demand risk, along with detailed discussion
on current and future market trends that are associated with the growth of the
market.
The global oxycodone market is anticipated
to attain a notable CAGR over the forecast period, i.e., 2022 – 2030. The
market is segmented by route of administration into oral, intravenous, and others. Among these segments,
the oral segment is anticipated to gain the largest market share over the
forecast period owing to the safer action of oxycodone when administered
orally. Moreover, the oxycodone tablets contain other drugs, which reduces the
abuse potential of the drug, which is estimated to boost the segment growth.
Get a Sample PDF
Brochure: https://www.researchnester.com/sample-request-3794
The global oxycodone market is
estimated to grow on the back of growing cases of cancer globally.
As per the data by the National Cancer Institute, over 18.1 million new cases
of cancer were reported globally in 2018. Moreover, the growing medical
research activities, along with rising investment in the R&D activities in
healthcare sector, are estimated to boost the market growth. Furthermore,
oxycodone has lower abuse potential as compared to other opioids, which is
projected to fuel the market growth.
On the basis of geographical analysis, the
global oxycodone market is segmented into five major regions including North
America, Europe, Asia Pacific, Latin America and Middle East & Africa
region. The market in the North America region is anticipated to gain the
largest market share throughout the forecast period owing to the rising cases
of cancer in developed nations, along with the presence of major research
institutes in the region,. According to the US National Cancer Institute, an
estimated of 1,806,590 new cases of cancer were diagnosed in the United States
in 2020. Moreover, high healthcare expenditure, and increasing R&D
activities, are estimated to boost the market growth.
The
research is global in nature and covers detailed analysis on the market in
North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain,
Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden,
Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America
(Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India,
Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand,
Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE,
Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East
and Africa). In addition, analysis comprising market size, Y-O-Y growth &
opportunity analysis, market players’ competitive study, investment
opportunities, demand for future outlook etc. has also been covered and
displayed in the research report.
Browse full report summary : https://www.researchnester.com/reports/oxycodone-market/3794
Rising
Prevalence of Cancer Globally to Boost the Market Growth
According to the data by the World Health
Organization (WHO), the cancer mortality rate grew from 9.6 million in 2018 to
over 10 million in 2020.
Oxycodone is prescribed to cancer patients
who experience extreme pain. It is generally given on a regular basis, as it is
less addictive, when taken orally. Moreover, the growing demand for opium-based
analgesics to relieve the pain for cancer patients is anticipated to boost the
market growth.
However, the side effects and addictive
nature of opioids are expected to operate as key restraint to the growth of global
oxycodone market over the forecast
period.
This report also provides the existing
competitive scenario of some of the key players of the global oxycodone market which includes company profiling of
Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Bayer AG, Abbott
Laboratories, Merck & Co., Inc., Esteve Pharmaceuticals, S.A., Validus
Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd., and Siemens Healthcare
GmbH. The profiling enfolds key information of the companies which encompasses
business overview, products and services, key financials and recent news and
developments. On the whole, the report depicts detailed overview of the global oxycodone
market that will help industry
consultants, equipment manufacturers, existing players searching for expansion
opportunities, new players searching possibilities and other stakeholders to
align their market centric strategies according to the ongoing and expected trends in
the future.
Request
Report Sample@ https://www.researchnester.com/sample-request-3794
Research Nester is a leading service provider for
strategic market research and consulting. We aim to provide unbiased,
unparalleled market insights and industry analysis to help industries,
conglomerates and executives to take wise decisions for their future marketing
strategy, expansion and investment etc. We believe every business can expand to
its new horizon, provided a right guidance at a right time is available through
strategic minds. Our out of box thinking helps our clients to take wise
decision in order to avoid future uncertainties.
Contact for more
Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
%20Security%20Market.jpg)
No comments:
Post a Comment